Quarterly report pursuant to Section 13 or 15(d)

Convertible Notes Payable (Details Narrative)

v3.19.3
Convertible Notes Payable (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended
Jan. 31, 2018
Nov. 24, 2017
May 31, 2018
Mar. 31, 2019
Jun. 30, 2018
Sep. 30, 2019
Jun. 28, 2019
Debt conversion price per share     $ 1.90        
Gross proceeds from convertible debt           $ 3,928  
Number of common stock issued       $ 3,928 $ 7,684    
Shares issued price per share             $ 2.35
Board of Directors [Member]              
Convertible note interest rate, percentage     8.00%        
Debt conversion price per share     $ 1.90        
Accrued interest     $ 2,062        
Debt conversion converted instrument, shares issued     1,085,105        
Securities Purchase Agreement [Member]              
Gross proceeds from convertible debt     $ 8,428        
Number of common stock issued     $ 4,435,527        
Shares issued price per share     $ 1.90        
Proceeds from issuance of public offering     $ 7,680        
Securities Purchase Agreement [Member] | Convertible Notes Payable [Member] | OPKO Health, Inc. [Member]              
Debt instrument, principal amount $ 1,000            
Additional principal amount of debt $ 1,000            
Convertible note interest rate, percentage 8.00%            
Debt maturity date Jan. 31, 2020            
Debt conversion price per share $ 8.10            
Gross proceeds from convertible debt $ 10,000            
Securities Purchase Agreement [Member] | Two Investors [Member] | Convertible Notes [Member]              
Debt instrument, principal amount   $ 1,000          
Additional principal amount of debt   $ 1,000          
Convertible note interest rate, percentage   8.00%          
Debt maturity date   Nov. 24, 2019          
Debt conversion price per share   $ 8.10          
Gross proceeds from convertible debt   $ 10,000